Drug Database
Back to search

Belgium· BE-AMP-SAM221225-00

Fasturtec 1.5 mg/ml

A rasburicase product containing rasburicase, registered in Belgium by Sanofi Winthrop Industrie. The same ATC class is registered in 13 of our 19 countries.

ATC V03AF07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFasturtec 1.5 mg/mlATCV03AF07REGISTER NO.BE-AMP-SAM221225-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rasburicaseAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rasburicase is registered in 13 of 19 countries.

Countries holding a registration under ATC V03AF07 (rasburicase), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search rasburicase products by name

Rasburicase · ATC V03AF07

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Rasburicase
Manufacturer
Sanofi Winthrop Industrie
Country
Belgium (BE)
ATC code
V03AF07
ATC class
Rasburicase
Defined daily dose
14 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0770669
  • be_apb
    1660695

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for rasburicase.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rasburicase against other medicinesHow interaction checks work

Rasburicase · interactions on record

25 records

  • 1 severe
  • 24 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • LidocainA01AE01moderate
  • TetracainA01AE02moderate
  • LidocaineC05AD01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rasburicase in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rasburicase products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fasturtec
  • Liechtenstein · Fasturtec
  • Norway · Fasturtec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/84f791a3-e961-453d-a094-95ad31323610
GET /v1/drugs/84f791a3-e961-453d-a094-95ad31323610?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Fasturtec 1.5 mg/ml",
  "name_fr": "Fasturtec 1.5 mg/ml",
  "name_nl": "Fasturtec 1.5 mg/ml",
  "amp_code": "SAM221225-00",
  "strengths": [
    "1.5000",
    "1.5000"
  ],
  "pack_count": 1,
  "substances": [
    "Rasburicase",
    "Disodium Hydrogen Phosphate Dodecahydrate",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Mannitol",
    "Sodium Dihydrogen Phosphate Dihydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Rasburicase",
  "authorisation_numbers": [
    "EU/1/00/170/001"
  ]
}
API referenceMCP serverPlans

See everything about rasburicase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console